Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
26,882,413
-
Share change
-
+6,987,904
-
Total reported value
-
$562,261,636
-
Put/Call ratio
-
145%
-
Price per share
-
$20.92
-
Number of holders
-
87
-
Value change
-
+$147,700,051
-
Number of buys
-
59
-
Number of sells
-
30
Institutional Holders of HARPOON THERAPEUTICS INC - COM (HARP) as of Q1 2021
As of 31 Mar 2021,
HARPOON THERAPEUTICS INC - COM (HARP) was held by
87 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
26,882,413 shares.
The largest 10 holders included
MPM Oncology Impact Management LP, MPM ASSET MANAGEMENT LLC, New Leaf Venture Partners, L.L.C., ORBIMED ADVISORS LLC, BlackRock Inc., Aquilo Capital Management, LLC, Avidity Partners Management LP, VANGUARD GROUP INC, FRANKLIN RESOURCES INC, and Artal Group S.A..
This page lists
87
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.